LR

Lakshmana Rao Sathupati

Active Director Designated Partner DIN 09376963
DIN 09376963 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmana Rao Sathupati

Data last updated:

Lakshmana Rao Sathupati is a Designated Partner at Borven Medical Llp (since 2021). The company operates in Chemicals.

DIN 09376963
Primary Designation Designated Partner
Industry Chemicals
First Appointment 21 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Oct 20212021Active

Board colleagues of Lakshmana Rao Sathupati

NameDINCompanyDesignation
Manoj Kumar Yalamati09317240Borven Medical LlpDesignated Partner
Preethi Borigorla09317239Borven Medical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Borven Medical Llp
Premium access

Shareholding and investment profile for Lakshmana Rao Sathupati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmana Rao Sathupati

Lakshmana Rao Sathupati currently holds 1 directorship: Borven Medical Llp (Designated Partner, since 21 Oct 2021).

Lakshmana Rao Sathupati was first appointed on 21 Oct 2021 as Designated Partner at Borven Medical Llp.

The current boards of Lakshmana Rao Sathupati's companies include Manoj Kumar Yalamati (Borven Medical Llp), Preethi Borigorla (Borven Medical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available